The patent is currently for sale on the companys website
Common Dosing Protocols for AOD9604 In Research In-Vitro Setting Dosing in published AOD9604 preclinical and human studies is variable, as it is determined by both the model and the research goals
In addition, it reverses intracellular acidosis (such as that in renal tubule acidosis), apparently by competing with diphosphopyridine nucleotide as a hydrogen receptor
Why are these booster shots needed
Calbindin and Girk2/Aldh1a1 define resilient vs vulnerable dopaminergic neurons in a primate Parkinsons disease model
Of note, that BPC 157 effect is particular (i.e., activated the phosphorylation of VEGFR2, Akt, and eNOS signaling pathway) and does not need other known ligands or shear stress (Hsieh et al., 2017)